Nigel Jones read Natural Sciences at Cambridge University. He has worked in the pharmaceutical industry for 32 years, almost exclusively in clinical research. Most of this time has been spent in assessing treatments for type 2 diabetes. He has been responsible for more than 20 international diabetes clinical trials, serving as a Steering Committee member for both the ADOPT and RECORD studies and as Clinical Investigation Leader for HARMONY Outcomes. He is a Director of Clinical Development within the Future Pipeline Discovery unit at GlaxoSmithKline and is based in the UK.